NRSN Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Neurosense Therapeutics Ltd (NRSN) Moving Averages Convergence Divergence (MACD) indicator is -0.0294, suggesting NRSN is Strong Sell.

Neurosense Therapeutics Ltd (NRSN) 20-Day simple moving average is 0.779, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it Sell.

Neurosense Therapeutics Ltd (NRSN) 60-Day simple moving average is 0.779, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it Sell.

Technical Analysis for NRSN

Technical Sentiment Analysis for Neurosense Therapeutics Ltd (NRSN) As of 2026-06-17, Neurosense Therapeutics Ltd (NRSN) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 15 technical signals, shows that 5 indicators are flashing buy, while 10 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NRSN stands at 36.55, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0294, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 10.064 and the Commodity Channel Index (CCI) at -130.591 further confirm a -0.0814 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NRSN is trading below its 60-day moving average of $0.779 and below its 200-day long-term moving average of $0.946. Key price levels to watch include the immediate resistance at $0.819 and strong support at $0.659. A break above $0.819 could signal a bull continuation, while falling below $0.659 may test the next Fibonacci floor at $0.585.

Neurosense Therapeutics Ltd (NRSN) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	0.499	0.585	0.659	0.744	0.819	0.904	0.979
Fibonacci	0.585	0.646	0.683	0.744	0.806	0.843	0.904

Neurosense Therapeutics Ltd (NRSN) Technical Indicators

2026-06-17

Name	Value
RSI_14	36.55
STOCHk_14_3_3	10.064
STOCHd_14_3_3	10.041
CCI_20	-130.591
AO_5_34	-0.1
MOM_10	-0.0814
MACD_12_26_9	-0.0294

Neurosense Therapeutics Ltd (NRSN) Relative Strength Index (RSI) is 36.55, creating a Neutral signal.

Neurosense Therapeutics Ltd (NRSN) Stochastic Oscillator is 10.064, creating a Buy signal.

Neurosense Therapeutics Ltd (NRSN) Stochastic RSI is 10.041, creating a Buy signal.

Neurosense Therapeutics Ltd (NRSN) Commodity Channel Index (CCI) is -130.591, creating a Buy signal.

Neurosense Therapeutics Ltd (NRSN) Awesome Oscillator is -0.1, creating a Sell signal.

Neurosense Therapeutics Ltd (NRSN) Momentum is -0.0814, creating a Sell signal.

Neurosense Therapeutics Ltd (NRSN) MACD is -0.0294, creating a Sell signal.

Neurosense Therapeutics Ltd (NRSN) Moving Average

2026-06-17

Period	Simple	Signal
MA_5	0.712	Sell
MA_10	0.733	Sell
MA_20	0.779	Sell
MA_60	0.779	Sell
MA_200	0.946	Sell
MA_250	1.09	Sell

Neurosense Therapeutics Ltd (NRSN) 5-Day simple moving average is 0.712, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 10-Day simple moving average is 0.733, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 20-Day simple moving average is 0.779, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 60-Day simple moving average is 0.779, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 200-Day simple moving average is 0.946, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

Neurosense Therapeutics Ltd (NRSN) 250-Day simple moving average is 1.09, while Neurosense Therapeutics Ltd (NRSN) share price is $0.699, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NRSN?

The overall technical consensus for Neurosense Therapeutics Ltd (NRSN) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 5 buy signals and 4 sell signals.

What are the key support and resistance levels for Neurosense Therapeutics Ltd (NRSN) today?

Based on pivot point calculations, Neurosense Therapeutics Ltd (NRSN) has an immediate support level at 0.659 and a major resistance level at 0.819. Traders also monitor the pivot point at 0.744 to determine the intraday trend direction.

Is Neurosense Therapeutics Ltd (NRSN) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Neurosense Therapeutics Ltd (NRSN) is currently 36.55. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Neurosense Therapeutics Ltd (NRSN)?

Neurosense Therapeutics Ltd (NRSN) Moving Averages Convergence Divergence (MACD) indicator is -0.0294, suggesting NRSN is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Neurosense Therapeutics Ltd.

How is Neurosense Therapeutics Ltd (NRSN) performing relative to its 200-day moving average?

Neurosense Therapeutics Ltd (NRSN) is currently trading at $0.699, which is below its 200-day simple moving average of 0.946. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.